JP2012514983A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012514983A5 JP2012514983A5 JP2011545540A JP2011545540A JP2012514983A5 JP 2012514983 A5 JP2012514983 A5 JP 2012514983A5 JP 2011545540 A JP2011545540 A JP 2011545540A JP 2011545540 A JP2011545540 A JP 2011545540A JP 2012514983 A5 JP2012514983 A5 JP 2012514983A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- composition
- cells
- pluripotent
- cultured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 26
- 239000000203 mixture Substances 0.000 claims 21
- 238000000034 method Methods 0.000 claims 13
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 7
- 208000015122 neurodegenerative disease Diseases 0.000 claims 7
- 229930002330 retinoic acid Natural products 0.000 claims 7
- 229960001727 tretinoin Drugs 0.000 claims 7
- 108020004999 messenger RNA Proteins 0.000 claims 6
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 5
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 5
- 102000007469 Actins Human genes 0.000 claims 4
- 108010085238 Actins Proteins 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 210000004748 cultured cell Anatomy 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 230000004770 neurodegeneration Effects 0.000 claims 3
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims 2
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 206010003246 arthritis Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims 1
- 108700018351 Major Histocompatibility Complex Proteins 0.000 claims 1
- 102000003729 Neprilysin Human genes 0.000 claims 1
- 108090000028 Neprilysin Proteins 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 claims 1
- 108010081355 beta 2-Microglobulin Proteins 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940000406 drug candidate Drugs 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 238000010186 staining Methods 0.000 claims 1
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14420609P | 2009-01-13 | 2009-01-13 | |
| US61/144,206 | 2009-01-13 | ||
| PCT/US2010/020884 WO2010083203A2 (en) | 2009-01-13 | 2010-01-13 | Non-embryonic stem cells and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012514983A JP2012514983A (ja) | 2012-07-05 |
| JP2012514983A5 true JP2012514983A5 (https=) | 2012-10-18 |
| JP5711149B2 JP5711149B2 (ja) | 2015-04-30 |
Family
ID=42337124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011545540A Expired - Fee Related JP5711149B2 (ja) | 2009-01-13 | 2010-01-13 | 非胚性幹細胞およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8394630B2 (https=) |
| EP (1) | EP2387609B1 (https=) |
| JP (1) | JP5711149B2 (https=) |
| CN (1) | CN102333863A (https=) |
| ES (1) | ES2675553T3 (https=) |
| WO (1) | WO2010083203A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8563307B2 (en) * | 2009-02-24 | 2013-10-22 | James Wang | Treatment of immunosuppression-related disorders |
| US8679474B2 (en) | 2010-08-04 | 2014-03-25 | StemBios Technologies, Inc. | Somatic stem cells |
| WO2012174225A2 (en) | 2011-06-14 | 2012-12-20 | The University Of North Carolina At Chapel Hill | Isolation, expansion and use of autologous pluripotent stem cells |
| TWI571513B (zh) * | 2011-09-28 | 2017-02-21 | 幹細胞生物科技股份有限公司 | 體幹細胞及其製備方法 |
| WO2014089268A2 (en) | 2012-12-06 | 2014-06-12 | StemBios Technologies, Inc. | Lgr5+ somatic stem cells |
| EP2746769A1 (en) | 2012-12-21 | 2014-06-25 | Stembios Technologies, Inc. | Method for evaluating effect of action on subject based on stem celldynamics |
| WO2014143383A1 (en) | 2013-03-13 | 2014-09-18 | Agilent Technologies, Inc. | Transposome tethered to a gene delivery vehicle |
| JP2018501189A (ja) * | 2014-11-19 | 2018-01-18 | ステムバイオス テクノロジーズ,インコーポレイテッド | 骨欠損を治療するための体性幹細胞 |
| WO2017070525A1 (en) | 2015-10-22 | 2017-04-27 | University Of Massachusetts | Methods and compositions for treating metabolic imbalance in neurodegenerative disease |
| US11413356B2 (en) | 2016-04-15 | 2022-08-16 | University Of Massachusetts | Methods and compositions for treating metabolic imbalance |
| TW202328432A (zh) * | 2021-08-26 | 2023-07-16 | 清華大學 | 誘導全能性幹細胞及其製備方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US6916654B1 (en) | 1992-06-29 | 2005-07-12 | Oklahoma Medical Research Foundation | Universal donor cells |
| US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| US5591625A (en) | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
| US5908779A (en) | 1993-12-01 | 1999-06-01 | University Of Connecticut | Targeted RNA degradation using nuclear antisense RNA |
| US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| AU6869198A (en) | 1997-03-25 | 1998-10-20 | Morphogenesis, Inc. | Universal stem cells |
| US20030161817A1 (en) * | 2001-03-28 | 2003-08-28 | Young Henry E. | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| WO2002045506A1 (en) * | 2000-10-26 | 2002-06-13 | University Of Florida | Drug screening system |
| EP1379624A2 (en) | 2000-11-27 | 2004-01-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Transfection of human embryonic stem cells |
| JP3977136B2 (ja) * | 2001-05-22 | 2007-09-19 | キヤノン株式会社 | コイルユニット |
| US7422736B2 (en) | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
| WO2004042023A2 (en) | 2002-11-01 | 2004-05-21 | Five Prime Therapeutics, Inc. | Stem cell libraries |
| EP1789540B9 (en) * | 2004-09-03 | 2012-02-22 | Moraga Biotechnology Inc. | Non-embryonic totipotent blastomer-like stem cells and methods therefor |
| EP2410044B1 (en) | 2004-12-29 | 2022-06-22 | Hadasit Medical Research Services And Development Ltd. | Stem cells culture systems |
| WO2007026353A2 (en) * | 2005-08-29 | 2007-03-08 | Technion Research & Development Foundation Ltd. | Media for culturing stem cells |
| WO2007082177A2 (en) * | 2006-01-06 | 2007-07-19 | Mount Sinai School Of Medicine Of New York University | Myeloid suppressor cells, methods for preparing them, and methods for using them for treating autoimmunity |
| EP1991666A4 (en) * | 2006-02-27 | 2009-06-10 | Moraga Biotech Corp | NON-EMBRYONIC TOTIPOTENT STEM CELLS OF BLASTOMERIC TYPE AND METHODS |
-
2010
- 2010-01-13 CN CN2010800045093A patent/CN102333863A/zh active Pending
- 2010-01-13 JP JP2011545540A patent/JP5711149B2/ja not_active Expired - Fee Related
- 2010-01-13 WO PCT/US2010/020884 patent/WO2010083203A2/en not_active Ceased
- 2010-01-13 US US12/686,584 patent/US8394630B2/en not_active Expired - Fee Related
- 2010-01-13 ES ES10732028.5T patent/ES2675553T3/es active Active
- 2010-01-13 EP EP10732028.5A patent/EP2387609B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012514983A5 (https=) | ||
| Zeng et al. | Single-cell RNA sequencing resolves spatiotemporal development of pre-thymic lymphoid progenitors and thymus organogenesis in human embryos | |
| Zwijnenburg et al. | Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretation | |
| Wu et al. | Immune tolerance of embryo implantation and pregnancy: the role of human decidual stromal cell-and embryonic-derived extracellular vesicles | |
| Tempest et al. | Endometrial stem cell markers: current concepts and unresolved questions | |
| Dey et al. | Dissecting the molecular relationship among various cardiogenic progenitor cells | |
| Zou et al. | CD4+ T cell immunity is dependent on an intrinsic stem-like program | |
| Papadimitropoulos et al. | Expansion of human mesenchymal stromal cells from fresh bone marrow in a 3D scaffold-based system under direct perfusion | |
| Abplanalp et al. | Single-cell technologies to decipher cardiovascular diseases | |
| Chihara et al. | Differentiation and characterization of Tr1 cells | |
| Biel et al. | Vascular smooth muscle cells from hypertensive patient-derived induced pluripotent stem cells to advance hypertension pharmacogenomics | |
| Liu et al. | Patient‐Derived Tumor Organoids Combined with Function‐Associated ScRNA‐Seq for Dissecting the Local Immune Response of Lung Cancer | |
| JP2012516686A5 (https=) | ||
| Liao et al. | Stereo-cell: Spatial enhanced-resolution single-cell sequencing with high-density DNA nanoball-patterned arrays | |
| Huang et al. | Development and evaluation of IL‐6 overexpressing mesenchymal stem cells (MSCs) | |
| Ragni et al. | Secreted factors and extracellular vesicles account for the immunomodulatory and tissue regenerative properties of bone-marrow-derived mesenchymal stromal cells for osteoarthritis | |
| Jiang et al. | Single-cell RNA-sequencing reveals interactions between endometrial stromal cells, epithelial cells, and lymphocytes during mouse embryo implantation | |
| Fong et al. | A serum-and feeder-free system to generate CD4 and regulatory T cells from human iPSCs | |
| Al Madhoun et al. | Comparative proteomic analysis identifies EphA2 as a specific cell surface marker for Wharton’s jelly-derived mesenchymal stem cells | |
| Watzling et al. | Three-dimensional breast cancer model to investigate CCL5/CCR1 expression mediated by direct contact between breast cancer cells and adipose-derived stromal cells or adipocytes | |
| Primak et al. | Novel immortalized human multipotent mesenchymal stromal cell line for studying hormonal signaling | |
| Na et al. | The IL-6 signaling pathway contributes critically to the immunomodulatory mechanism of human decidua-derived mesenchymal stromal cells | |
| Blinova et al. | Modulation of suppressive activity and proliferation of human regulatory T cells by splice-switching oligonucleotides targeting FoxP3 pre-mRNA | |
| Georgi et al. | MicroRNA levels as prognostic markers for the differentiation potential of human mesenchymal stromal cell donors | |
| Zhdanov et al. | Induction of FoxP3 Pre-mRNA alternative splicing to enhance the suppressive activity of regulatory T cells from amyotrophic lateral sclerosis patients |